Hereditary neuropathy with liability to pressure palsies (HNPP) is an autosomal dominant demyelinating neuropathy characterized by an increased susceptibility to peripheral nerve injury from trauma, compression, or shear forces. Patients with this condition are unique, necessitating distinct considerations for anesthesia and surgical teams. This review describes the etiology, prevalence, clinical presentation, and management of HNPP and presents contemporary evidence and recommendations for optimal care for HNPP patients in the perioperative period. While the incidence of HNPP is reported at 7–16:100,000, this figure may be an underestimation due to underdiagnosis, further complicating medicolegal issues. With the subtle nature of symptoms associated with HNPP, patients with this condition may remain unrecognized during the perioperative period, posing significant risks. Several aspects of caring for this population, including anesthetic choices, intraoperative positioning, and monitoring strategy, may deviate from standard practices. As such, a tailored approach to caring for this unique population, coupled with meticulous preoperative planning, is crucial and requires a multidisciplinary approach.
Background: Given the endemic opioid crisis in our communities, there is an important need for opioid‐sparing analgesia alternatives for invasive surgical procedures that use multimodal analgesia to help reduce or avoid opioid consumption perioperatively. Unfortunately, a significant challenge exists in reducing opioid consumption with procedures that are known to cause a significant amount of postoperative discomfort. Regional anesthesia via peripheral nerve blockade is a modality that can take advantage of pertinent anatomy, greatly reduce a patient’s postoperative pain, and minimize opioid consumption. Some anatomical locations, such as the hip joint, have complex innervation. For such anatomical locations, a single peripheral nerve block may fail to cover all the involved sensory nerves, and thus, incorporating additional regional blocks can synergistically provide sufficient analgesic coverage. Case Presentation: A 69‐year‐old man presented for revision total hip arthroplasty. Due to his previous history of opioid abuse, he requested an opioid‐free perioperative experience. The patient’s past medical history was complex, and he had suffered recurrent prosthetic joint infections. To accomplish opioid‐free perioperative analgesia for his revision hip arthroplasty, we utilized both the suprainguinal fascia iliaca block and the pericapsular nerve group block, in combination with surgeon‐administered local infiltration analgesia and oral and intravenous nonopioid systemic pain medications. The patient was successfully able to avoid opioids through the procedure and postoperative course, with the majority of his pain scores being zero out of 10 during his hospital admission. Conclusions: Complimentary regional nerve blocks, when combined with surgeon‐administered local infiltration analgesia and multiple systemic nonopioid medications, can provide sufficient analgesia to cover the complexly innervated hip joint and accomplish an opioid‐sparing revision total hip arthroplasty perioperative course.
Regional anesthesia for spine surgery is a relatively new and evolving area. Erector spinae plane blocks (ESPB) are a type of regional technique that has successfully managed acute postoperative pain in thoracic and lumbar spine surgeries. Using ESPB in cervical spine surgeries has shown to reduce intraoperative opioid needs and improve postoperative pain control, among other benefits. Liposomal bupivacaine has been shown potential in managing acute postoperative pain when injected at the surgical incision site. There is limited research on using liposomal bupivacaine in cervical spine surgery, especially with ESPB. We present a case of ESPB for cervical spine surgery performed successfully with liposomal bupivacaine.